Evidence map›Paper›PMID 30674666›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Prp8 impacts cryptic but not alternative splicing frequency.

Megan Mayerle, Samira Yitiz, Cameron Soulette, Lucero E Rogel, Andrea Ramirez, J Matthew Ragle, Sol Katzman, Christine Guthrie, Alan M Zahler

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Megan MayerleDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94143.
Samira YitizDepartment of Molecular, Cellular, and Developmental Biology and Center for Molecular Biology of RNA, University of California, Santa Cruz, CA 95064.
Cameron SouletteDepartment of Molecular, Cellular, and Developmental Biology and Center for Molecular Biology of RNA, University of California, Santa Cruz, CA 95064.
Lucero E RogelDepartment of Molecular, Cellular, and Developmental Biology and Center for Molecular Biology of RNA, University of California, Santa Cruz, CA 95064.
Andrea RamirezDepartment of Molecular, Cellular, and Developmental Biology and Center for Molecular Biology of RNA, University of California, Santa Cruz, CA 95064.
J Matthew RagleDepartment of Molecular, Cellular, and Developmental Biology and Center for Molecular Biology of RNA, University of California, Santa Cruz, CA 95064.
Sol KatzmanCenter for Biomolecular Science and Engineering, University of California, Santa Cruz, CA 95064.
Christine GuthrieDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94143; christineguthrie@gmail.com zahler@ucsc.edu.
Alan M ZahlerDepartment of Molecular, Cellular, and Developmental Biology and Center for Molecular Biology of RNA, University of California, Santa Cruz, CA 95064; christineguthrie@gmail.com zahler@ucsc.edu.
University of California, Santa Cruz · USUniversity of California, San Francisco · US

Funding

BIOSYNTHESIS OF RNASR01GM021119 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUTHRIE, CHRISTINE · 1985 to 2015
$12.9M
UNIVERSITY OF CALIFORNIA, SANTA CRUZ IMSD PROGRAMR25GM058903 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI JURICA, MELISSA S · 1999 to 2019
$12.2M
UCSC PREPR25GM104552 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI William T. SULLIVAN · 2013 to 2026
$3.9M
Training Program/Molecular/Cell/Developmental BiologyT32GM008646 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI STROME, SUSAN · 1999 to 2018
$3.7M
NIGMS NIH HHS R01 GM021119NIGMS NIH HHS R25 GM058903NIGMS NIH HHS R25 GM104552NIGMS NIH HHS T32 GM008646
6 · The paper itself

Abstract

Pre-mRNA splicing must occur with extremely high fidelity. Spliceosomes assemble onto pre-mRNA guided by specific sequences (5' splice site, 3' splice site, and branchpoint). When splice sites are mutated, as in many hereditary diseases, the spliceosome can aberrantly select nearby pseudo- or "cryptic" splice sites, often resulting in nonfunctional protein. How the spliceosome distinguishes authentic splice sites from cryptic splice sites is poorly understood. We performed a

Indexed as

Alternative SplicingRNA Splice SitesAllelesAmino AcidsAmino Acid SequenceAmino Acid SubstitutionAnimalsCaenorhabditis elegansConserved SequenceGene FrequencyGenetic LociModels, MolecularProtein ConformationRibonucleoprotein, U4-U6 Small NuclearRibonucleoprotein, U5 Small NuclearRNA PrecursorsAmino AcidsPRP8 protein, S cerevisiaeRibonucleoprotein, U4-U6 Small NuclearRibonucleoprotein, U5 Small NuclearRNA PrecursorsRNA Splice SitesSaccharomyces cerevisiae Proteinsalternative splicingCRISPR mutagenesiscryptic splicingPRP8spliceosome

Identifiers

PMID30674666
PMCPMC6369775
OpenAlexW2914903875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.